Protect. Contour. Irradiate.

The new SpaceOAR Vue™ Hydrogel is an absorbable hydrogel spacer designed to protect your patient’s rectum by minimising negative radiation side effects during prostate cancer treatment. It is safe, easily injectable and visible on CT scan, intended to improve contouring accuracy and to potentially optimise treatment planning. See how it works and watch recorded webinars from international experts.

What is your area of expertise?
 
 
Discover how SpaceOAR Vue Hydrogel may help you provide better care for your patients, from treatment to recovery and beyond.
spaceOAR Vue
Discover how SpaceOAR Vue Hydrogel could help you protect your patients’ quality of life through potentially more efficient and effective radiotherapy treatment.
spaceOAR Vue
        Interested in SpaceOAR Vue Hydrogel?
 
 

 

Contact us

 

What prostate cancer patients say
 
 
Patients treated with SpaceOAR Hydrogel report a higher quality of life after prostate cancer radiation 
treatment and experience minimal adverse side effects.1
                
Discover more stories


Access patient information
website

contact us

Visit now

Need more
information?

contact us

Contact us

Learn more about SpaceOAR Vue™ Hydrogel

contact us

Product information




References

1. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.

* A Randomised Feasibility Study Evaluating Stereotactic Prostate RadioTherapy in High-Risk Localised Prostate Cancer With or Without Elective Nodal Irradiation SPORTS High-Risk Study. Sponsored by Boston Scientific.

** Dose-escalated prostate stereotactic radiotherapy: A feasibility study using rectal spacer and urethra sparing. Lewin Ron, Bar-Orian Idan, Honig Nir, Tsvang Lev, Ben-Ayun Maoz, Weiss Ilana, Simon Zvi

Disclaimer

Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.

SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum. As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection; pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR and SpaceOAR Vue Hydrogels into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR and SpaceOAR Vue Hydrogels intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.

Top